ZOMIG RAPIMELT

国家: 以色列

语言: 英文

来源: Ministry of Health

现在购买

产品特点 产品特点 (SPC)
17-08-2016
公众评估报告 公众评估报告 (PAR)
17-08-2016

有效成分:

ZOLMITRIPTAN

可用日期:

ASTRA ZENECA (ISRAEL) LTD

ATC代码:

N02CC03

药物剂型:

TABLETS SOLUBLE IN MOUTH

组成:

ZOLMITRIPTAN 2.5 MG

给药途径:

PER OS

处方类型:

Required

厂商:

ASTRA ZENECA UK LIMITED

治疗组:

ZOLMITRIPTAN

治疗领域:

ZOLMITRIPTAN

疗效迹象:

Acute treatment of migraine with or without aura.

授权日期:

2012-05-31

产品特点

                                ZOMIG RAPIMELT approved 0509
Page of 10
1
“This leaflet format has been determined by the Ministry of Health
and the content thereof has been checked and
approved 01.2012.”
SUMMARY OF PRODUCT CHARACTERISTICS ZOMIG 2.5 MG SOLUBLE IN MOUTH
1.
TRADENAME OF THE MEDICINAL PRODUCT
‘Zomig Rapimelt’ 2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Tablets soluble in mouth containing 2.5 mg of zolmitriptan.
For excipients: see Section 6.1
3.
PHARMACEUTICAL FORM
Tablets soluble in mouth.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
‘Zomig Rapimelt’ is indicated for the acute treatment of migraine
with or without
aura.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
The recommended dose of ‘Zomig Rapimelt’ to treat a migraine
attack is 2.5 mg.
‘Zomig Rapimelt’ rapidly dissolves when placed on the tongue and
is swallowed
with the patient’s saliva. A drink of water is not required when
taking ‘Zomig
Rapimelt’. ‘Zomig Rapimelt’ can be taken when water is not
available thus
allowing early administration of treatment for a migraine attack. This
formulation
may also be beneficial for patients who suffer from nausea and are
unable to drink
during a migraine attack, or for patients who do not like swallowing
conventional
tablets.
If symptoms persist or return within 24 hours, a second dose of
zolmitriptan has
been shown to be effective. If a second dose is required, it should
not be taken
within 2 hours of the initial dose.
If a patient does not achieve satisfactory relief with 2.5 mg doses,
subsequent
attacks can be treated with 5 mg doses of ‘Zomig Rapimelt’. In
those patients who
respond, significant efficacy is apparent within 1 hour of dosing with
zolmitriptan.
Zolmitriptan is equally effective whenever the tablets are taken
during a migraine
attack; although it is advisable that ‘Zomig Rapimelt’ is taken as
early as possible
after the onset of migraine headache.
ZOMIG RAPIMELT approved 0509
Page of 10
2
In the event of recurrent attacks, it is recommended that the total
intake of ‘Zomig
Rap
                                
                                阅读完整的文件
                                
                            

其他语言的文件

资料单张 资料单张 希伯来文 17-08-2016

搜索与此产品相关的警报